For more information about Cysto-Conray® II, please see the Full Prescribing Information.
For more than 35 years, clinicians have relied on MD-Gastroview® for radiographic examination of segments of the gastrointestinal tract, and as a bowel marker in CT.
Important Safety Information2
Indication and Usage
Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the prerequisite training and with a thorough knowledge of the particular procedure to be performed. Appropriate facilities should be available for coping with any complication of administration, as well as for treatment of reaction to the contrast medium.
Use in Specific Populations
You are encouraged to report negative side effects of prescription drugs to the FDA.Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
MD-Gastroview® (diatrizoate meglumine and diatrizoate sodium solution USP), 367 mg/mL
MD-Gastroview® is a registered trademark of Guerbet LLC or its affiliates, and is available by prescription only.
Legal Copyright 2018 Guerbet